Taylor & Francis Handbook of Intelligent Scaffolds for Tissue Engineering and Regenerative Medicine

Product Description Millions of patients suffer from end-stage organ failure or tissue loss annually, and the only solution might be organ and/or tissue transplantation. To avoid poor biocompatibility–related problems and donor organ shortage, however, around 20 years ago a new, hybridized method combining cells and biomaterials was introduced as an alternative to whole-organ and tissue transplantation for diseased, failing, or malfunctioning organs―regenerative medicine and tissue engineering. This handbook focuses on all aspects of intelligent scaffolds, from basic science to industry to clinical applications. Its 10 parts, illustrated throughout with excellent figures, cover stem cell engineering research, drug delivery systems, nanomaterials and nanodevices, and novel and natural biomaterials. The book can be used by advanced undergraduate- and graduate-level students of stem cell and tissue engineering and researchers in macromolecular science, ceramics, metals for biomaterials, nanotechnology, chemistry, biology, and medicine, especially those interested in tissue engineering, stem cell engineering, and regenerative medicine. About the Author Gilson Khang is a professor at the Department of PolymerNano Science and Technology, Chonbuk National University (Korea) and a visiting professor at Tsinghua University, Peking University, and Zhejiang University (China) and the Wake Forest Institute of Regenerative Medicine (USA). Dr. Khang was elected as the founding Fellow of Tissue Engineering and Regenerative Medicine (FTERM) in 2012. He is a member of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and a founding member of the TERMIS-AP chapter, of which he is also the continental chair since 2015. He is also an executive board member of TERMIS Global and since 2016 the TERMIS Global president-elect. From 2004 to 2009, Dr. Khang was editor-in-chief of Journal of Tissue Engineering and Regenerative Medicine. He has also served as co-editor-in-chief of International Journal of Tissue Regeneration, in addition to being on the editorial board of many reputed scientific journals. He has co-authored/edited 10 books and published around 550 original research papers and 200 editorials, reviews, and book chapters. His major scientific contribution has been to the analysis of natural/synthetic hybrid scaffolds to reduce host inflammation reactions, as well as the commercialization of tissue-engineered cartilage, bone, retinal pigment epithelium, and corneal endothelium.